Thursday, Jul 11, 2024 · SEC filings
What the smart money revealed on Jul 11
290 insider filings came in. We hid 48 planned (10b5-1) sellers and 176 people whose filings were routine, like grants and tax withholding.
Douglas Elliman (DOUG) Director Michael Liebowitz bought $233K
197,398 shares on the open market. Not a grant or an option exercise.
Alto Neuroscience (ANRO) Chief Medical Officer Adam Savitz bought $191K
15,000 shares on the open market. Not a grant or an option exercise.
Douglas Elliman (DOUG) Executive Vice President and COO Richard Lampen bought $90K
75,000 shares on the open market. Not a grant or an option exercise.
NVIDIA (NVDA) Director Mark Stevens sold $104M
Not marked as a planned 10b5-1 sale. Sold 8% of the shares they held directly. Still holds 8.74M shares.
Oracle (ORCL) Chief Corporate Architect Edward Screven sold $60.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 2.63M shares directly.
Argan (AGX) Director Rainer Bosselmann sold $1.18M
Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 247,719 shares.
Show 15 more real buys
Show 18 more real sales
13F season
Holdings as of Jun 30, 2024 are due Aug 14
54 funds have filed so far. 50 filed for the quarter before.
Biggest real insider buys, Jul 5–11
Open-market buys by officers and directors, filed in the 7 days up to Jul 11.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.